The inhibitor effectively suppressed the activity of SR proteins, SRSF4 and SRSF6, disrupting the RNA splicing process and inhibiting the growth and proliferation of the pancreatic cancer cells. This evidence concerns the gene SRSF6 and familial pancreatic carcinoma.